收稿日期: 2020-02-17
网络出版日期: 2020-06-25
基金资助
国家自然科学基金项目(81970758)
赵红燕, 刘建民 . 2019年《糖尿病患者骨折风险管理中国专家共识》解读[J]. 诊断学理论与实践, 2020 , 19(03) : 225 -228 . DOI: 10.16150/j.1671-2870.2020.03.004
| [1] | Xu Y, Wang LM, He J, et al. Prevalence and control of diabetes in Chinese adults[J]. JAMA, 2013, 310(9):948-959. |
| [2] | Bragg F, Holmes MV, Iona A, et al. Association between diabetes and cause-specific mortality in rural and urban areas of China[J]. JAMA, 2017, 317(3):280-289. |
| [3] | Miyake H, Kanazawa I, Sugimoto T. Association of bone mineral density, bone turnover markers, and vertebral fractures with all-cause mortality in type 2 diabetes mellitus[J]. Calcif Tissue Int, 2018, 102(1):1-13. |
| [4] | Bonds DE, Larson JC, Schwartz AV, et al. Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study[J]. J Clin Endocrinol Metab, 2006, 91(9):3404-3410. |
| [5] | Gilbert MP, Pratley RE. The impact of diabetes and diabetes medications on bone health[J]. Endocr Rev, 2015, 36(2):194-213. |
| [6] | Guo Y, Wang YF, Cheng F, et al. Assessment of risk factors for fractures in patients with type 2 diabetes over 60 years old: a cross-sectional study from northeast China[J]. J Diabetes Res, 2020, 2020:1508258. |
| [7] | Stumpf U, Hadji P, van den Boom L, et al. Incidence of fractures in patients with type 1 diabetes mellitus-a retrospective study with 4420 patients[J]. Osteoporos Int, 2020, 31(7):1315-1322. |
| [8] | Kaur H, Joshee P, Franquemont S, et al. Bone mineral content and bone density is lower in adolescents with type 1 diabetes: A brief report from the RESISTANT and EMERALD studies[J]. J Diabetes Complications, 2018, 32(10):931-933. |
| [9] | Shah VN, Harrall KK, Shah CS, et al. Bone mineral density at femoral neck and lumbar spine in adults with type 1 diabetes: a meta-analysis and review of the literature[J]. Osteoporos Int, 2017, 28(9):2601-2610. |
| [10] | Thong EP, Herath M, Weber DR, et al. Fracture risk in young and middle-aged adults with type 1 diabetes mellitus: A systematic review and meta-analysis[J]. Clin Endocrinol (Oxf), 2018, 89(3):314-323. |
| [11] | Janghorbani M, van Dam RM, Willett WC, et al. Syste-matic review of type 1 and type 2 diabetes mellitus and risk of fracture[J]. Am J Epidemiol, 2007, 166(5):495-505. |
| [12] | Nicodemus KK, Folsom AR, Iowa Women's Health S. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women[J]. Diabetes Care, 2001, 24(7):1192-1197. |
| [13] | Jiajue RZ, Qi X, Jiang Y, et al. Incident fracture risk in type 2 diabetic postmenopausal women in mainland China: Peking Vertebral Fracture Study[J]. Calcif Tissue Int, 2019, 105(5):466-475. |
| [14] | Schwartz AV, Vittinghoff E, Bauer DC, et al. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes[J]. JAMA, 2011, 305(21):2184-2192. |
| [15] | Yamamoto M, Yamaguchi T, Yamauchi M, et al. Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications[J]. J Bone Miner Res, 2009, 24(4):702-709. |
| [16] | Jiang N, Xia W. Assessment of bone quality in patients with diabetes mellitus[J]. Osteoporos Int, 2018, 29(8):1721-1736. |
| [17] | 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017)[J]. 中华骨质疏松和骨矿盐疾病杂志, 2017, 10(5):413-443. |
| [18] | Ho-Pham LT, Nguyen TV. Association between trabecular bone score and type 2 diabetes: a quantitative update of evidence[J]. Osteoporos Int, 2019, 30(10):2079-2085. |
| [19] | Chen FP, Kuo SF, Lin YC, et al. Status of bone strength and factors associated with vertebral fracture in postmenopausal women with type 2 diabetes[J]. Menopause, 2019, 26(2):182-188. |
| [20] | Carvalho AL, Massaro B, Silva L, et al. Emerging aspects of the body composition, bone marrow adipose tissue and skeletal phenotypes in type 1 diabetes mellitus[J]. J Clin Densitom, 2019, 22(3):420-428. |
| [21] | Burghardt AJ, Issever AS, Schwartz AV, et al. High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus[J]. J Clin Endocrinol Metab, 2010, 95(11):5045-5055. |
| [22] | Samelson EJ, Demissie S, Cupples LA, et al. Diabetes and deficits in cortical bone density, microarchitecture, and bone size: Framingham HR-pQCT Study[J]. J Bone Miner Res, 2018, 33(1):54-62. |
| [23] | Giangregorio LM, Leslie WD, Lix LM, et al. FRAX underestimates fracture risk in patients with diabetes[J]. J Bone Miner Res, 2012, 27(2):301-308. |
| [24] | Iki M, Fujita Y, Tamaki J, et al. Trabecular bone score may improve FRAX(R) prediction accuracy for major osteoporotic fractures in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men(FORMEN) Cohort Study[J]. Osteoporos Int, 2015, 26(6):1841-1848. |
| [25] | Leslie WD, Johansson H, McCloskey EV, et al. Comparison of methods for improving fracture risk assessment in diabetes: The Manitoba BMD Registry[J]. J Bone Miner Res, 2018, 33(11):1923-1930. |
| [26] | Habib ZA, Havstad SL, Wells K, et al. Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus[J]. J Clin Endocrinol Metab, 2010, 95(2):592-600. |
| [27] | Lin HF, Liao KF, Chang CM, et al. Use of thiazolidinediones and risk of hip fracture in old people in a case-control study in Taiwan[J]. Medicine (Baltimore), 2017, 96(36):e7712. |
| [28] | Erythropoulou-Kaltsidou A, Polychronopoulos G, Tziomalos K. Sodium-glucose co-transporter 2 inhibitors and fracture risk[J]. Diabetes Ther, 2020, 11(1):7-14. |
| [29] | Ben-Porat T, Elazary R, Sherf-Dagan S, et al. Bone health following bariatric surgery: implications for mana-gement strategies to attenuate bone loss[J]. Adv Nutr, 2018, 9(2):114-127. |
| [30] | Lu CW, Chang YK, Chang HH, et al. Fracture risk after bariatric surgery: A 12-year nationwide cohort study[J]. Medicine (Baltimore), 2015, 94(48):e2087. |
| [31] | Ferrari SL, Abrahamsen B, Napoli N, et al. Diagnosis and management of bone fragility in diabetes: an emerging challenge[J]. Osteoporos Int, 2018, 29(12):2585-2596. |
/
| 〈 |
|
〉 |
